| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8296100 | Biochemical and Biophysical Research Communications | 2017 | 9 Pages |
Abstract
We investigated the role of the CXCL17-CXCR8 (GPR35) axis in breast cancer for the first time. CXCL17 is a potential oncogene and promising therapeutic target, is an independent biomarker of poor prognosis in patients with breast cancer, and can promote proliferation and migration of breast cancer cells in vitro and in vivo.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ya Jie Guo, Yu Jie Zhou, Xiao Li Yang, Zhi Min Shao, Zhou Luo Ou,